LOADING...
Trump hits some drugmakers with 100% tariffs
The plan imposes a 100% tariff on certain imported patented medicines and their key ingredients

Trump hits some drugmakers with 100% tariffs

Apr 03, 2026
11:11 am

What's the story

US President Donald Trump has announced a new tariff regime targeting pharmaceutical companies that have not signed up for his "Most Favored Nation" pricing scheme. The plan imposes a 100% tariff on certain imported patented medicines and their key ingredients. The move is intended to push drugmakers to bring production to the US and reduce prices for American consumers.

Compliance period

Tariffs to be effective from summer

The new tariffs will come into effect later this summer, giving large pharmaceutical companies a 120-day window to comply. Smaller firms have a slightly longer period of 180 days. However, there are broad exemptions in the order. Companies that agree to join the pricing initiative or commit to building US manufacturing facilities can significantly reduce or avoid these tariffs altogether.

Incentives

Production shift could lead to reduced tariffs

Companies that shift production to the US could see tariffs reduced to as low as 20%. Those based in regions with existing trade agreements, such as the European Union, Japan, South Korea and Switzerland, will face lower tariffs of around 15%, while UK-based firms will be subject to about 10%. The administration has already secured agreements with over a dozen pharmaceutical companies, offering temporary tariff relief in exchange for pricing concessions and domestic investment.

Advertisement

Trade escalation

Trump's trade strategy faces pushback

The new tariffs mark a major escalation in Trump's trade strategy, especially after a US Supreme Court ruling earlier this year limited some of his previous tariff powers. The move comes amid fears within Trump's own party that aggressive trade measures could push up costs for consumers already grappling with inflation. However, officials insist the changes will not significantly impact affordability, arguing that price effects will vary but remain manageable overall.

Advertisement

Tariff revision

Revision of tariffs on steel, aluminium, copper imports

Along with the pharmaceutical push, Trump has also revised tariffs on steel, aluminum, and copper imports to counter alleged price manipulation by foreign exporters. The new rules will see the existing 50% tariff on primary metals calculated based on US purchase prices instead of declared export values. Products with high metal content such as household appliances will face a 25% tariff if the metal exceeds a certain percentage of total weight.

Advertisement